Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

PURPOSE: A multicenter phase II study was conducted to assess the efficacy of rituximab, methotrexate, procarbazine, and vincristine (R-MPV) followed by consolidation reduced-dose whole-brain radiotherapy (rdWBRT) and cytarabine in primary CNS lymphoma. PATIENTS AND METHODS: Patients received induct...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Oncol
Päätekijät: Morris, Patrick G., Correa, Denise D., Yahalom, Joachim, Raizer, Jeffrey J., Schiff, David, Grant, Barbara, Grimm, Sean, Lai, Rose K., Reiner, Anne S., Panageas, Kathy, Karimi, Sasan, Curry, Richard, Shah, Gaurav, Abrey, Lauren E., DeAngelis, Lisa M., Omuro, Antonio
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2013
Aiheet:
Original Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5569679/
https://ncbi.nlm.nih.gov/pubmed/24101038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.50.4910
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia